Use of a Modified α-N-Acetylgalactosaminidase in the Development of Enzyme Replacement Therapy for Fabry Disease

Authors

Keywords

Journal

Volume 85, Issue 5, Pages 569-580

Publisher

Elsevier BV

Online

2009-10-23

DOI

10.1016/j.ajhg.2009.09.016

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now